These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23209746)
1. RAD52 variants predict platinum resistance and prognosis of cervical cancer. Shi TY; Yang G; Tu XY; Yang JM; Qian J; Wu XH; Zhou XY; Cheng X; Wei Q PLoS One; 2012; 7(11):e50461. PubMed ID: 23209746 [TBL] [Abstract][Full Text] [Related]
2. [Genetic variation in DNA repair gene RAD52 is associated with the response to platinum-based chemotherapy in SCLC patients]. Li HM; Yuan P; Yu DK; Ma F; Tan WW; Feng T; Yang J; Huang Y; Lin DX; Xu BH; Tan W Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):504-9. PubMed ID: 27531263 [TBL] [Abstract][Full Text] [Related]
3. RAD52 gene polymorphisms are associated with risk of colorectal cancer in a Chinese Han population. Zhang L; Zhang Y; Tang CH; Su CM Medicine (Baltimore); 2017 Dec; 96(49):e8994. PubMed ID: 29245274 [TBL] [Abstract][Full Text] [Related]
4. A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese. Lu C; Chen YD; Han S; Wei J; Ge Y; Pan W; Jiang T; Qiu XG; Yang M J Neurooncol; 2014 Oct; 120(1):11-7. PubMed ID: 25012956 [TBL] [Abstract][Full Text] [Related]
5. Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes. Shi TY; Cheng X; Yu KD; Sun MH; Shao ZM; Wang MY; Zhu ML; He J; Li QX; Chen XJ; Zhou XY; Wu X; Wei Q Carcinogenesis; 2013 Apr; 34(4):770-8. PubMed ID: 23299407 [TBL] [Abstract][Full Text] [Related]
6. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma. Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511 [TBL] [Abstract][Full Text] [Related]
7. Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G Ther Adv Respir Dis; 2020; 14():1753466620918192. PubMed ID: 32401173 [TBL] [Abstract][Full Text] [Related]
8. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. Siraj AK; Al-Rasheed M; Ibrahim M; Siddiqui K; Al-Dayel F; Al-Sanea O; Uddin S; Al-Kuraya K J Endocrinol Invest; 2008 Oct; 31(10):893-9. PubMed ID: 19092295 [TBL] [Abstract][Full Text] [Related]
10. Distinct roles of RAD52 and POLQ in chromosomal break repair and replication stress response. Kelso AA; Lopezcolorado FW; Bhargava R; Stark JM PLoS Genet; 2019 Aug; 15(8):e1008319. PubMed ID: 31381562 [TBL] [Abstract][Full Text] [Related]
11. Functional characterization of RAD52 as a lung cancer susceptibility gene in the 12p13.33 locus. Lieberman R; Xiong D; James M; Han Y; Amos CI; Wang L; You M Mol Carcinog; 2016 May; 55(5):953-63. PubMed ID: 26013599 [TBL] [Abstract][Full Text] [Related]
13. Increased risk of differentiated thyroid carcinoma with combined effects of homologous recombination repair gene polymorphisms in an Iranian population. Fayaz S; Karimmirza M; Tanhaei S; Fathi M; Torbati PM; Fard-Esfahani P Asian Pac J Cancer Prev; 2014 Jan; 14(11):6727-31. PubMed ID: 24377596 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China. Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853 [TBL] [Abstract][Full Text] [Related]
15. Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro. Tanaka T; Yukawa K; Umesaki N Eur J Gynaecol Oncol; 2007; 28(5):352-5. PubMed ID: 17966212 [TBL] [Abstract][Full Text] [Related]
16. The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations. Adamson AW; Ding YC; Mendez-Dorantes C; Bailis AM; Stark JM; Neuhausen SL Mol Oncol; 2020 Jun; 14(6):1124-1133. PubMed ID: 32175645 [TBL] [Abstract][Full Text] [Related]
17. Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility. Jiang Y; Qin Z; Hu Z; Guan X; Wang Y; He Y; Xue J; Liu X; Chen J; Dai J; Jin G; Ma H; Wang S; Shen H Carcinogenesis; 2013 Mar; 34(3):689-93. PubMed ID: 23188672 [TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer. Li T; Peng J; Zeng F; Zhang K; Liu J; Li X; Ouyang Q; Wang G; Wang L; Liu Z; Liu Y Int J Clin Pharmacol Ther; 2017 Oct; 55(10):774-780. PubMed ID: 28737129 [TBL] [Abstract][Full Text] [Related]
19. Aberrant Expression of RAD52, Its Prognostic Impact in Rectal Cancer and Association with Poor Survival of Patients. Ho V; Chung L; Singh A; Lea V; Abubakar A; Lim SH; Chua W; Ng W; Lee M; Roberts TL; de Souza P; Lee CS Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143539 [TBL] [Abstract][Full Text] [Related]
20. LIG4 and RAD52 DNA repair genes polymorphisms and systemic lupus erythematosus. De Azevêdo Silva J; Pancotto JA; Donadi EA; Crovella S; Sandrin-Garcia P Mol Biol Rep; 2014; 41(4):2249-56. PubMed ID: 24415301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]